Caffeine for Hypoxic-Ischemic Encephalopathy
NCT03913221
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Hypoxic-Ischemic Encephalopathy
Interventions
DRUG:
Caffeine Citrate 5 mg/kg
DRUG:
Caffeine Citrate 10 mg/kg
Sponsor
University of North Carolina, Chapel Hill
Collaborators
[object Object]